Christopher A. Muller

Chris Muller is currently the Chief Commercial Officer of Mati Therapeutics, and previously held the same position at QLT Inc. Prior to joining QLT, Mr. Muller was responsible for several business units at Abbott Medical Optics including Vice President of Eye Care, Medical Marketing and the Refractive Business Unit. Major global brand responsibility included VISX® and IntraLase® laser platforms, multipurpose contact lens solutions, artificial tear development and commercialization, plus multiple ophthalmic surgical products. From June 1989 to July 2005, Mr. Muller was employed at Allergan Inc., a pharmaceutical and device company, where he built an extensive background with ocular pharmaceutical and surgical products plus Botox®, including sales, health economics, worldwide medical marketing, and product management. His positions ranged from sales and sales management to Vice President of Medical Marketing. He was responsible for multiple products in glaucoma, anti-infective, anti-inflammatory, dermatology and neurology categories including Alphagan®, Zymar®, Ocuflox®, Acular®, Lumigan®, Pred Forte®, Botox®, Refresh® and Tazorac®. Chris also participated in several glaucoma product launches including the Alphagan and Lumigan launches while at Allergan and he has extensive commercial experience in all major markets in ophthalmology. Mr. Muller has a Bachelor of Arts degree in Biology from Whittier College and a Masters of Business Administration from Whittier/Pepperdine University.